Charles River Laboratories (CRL) PT Increases to $83 - UBS

May 5, 2016 9:00 AM

UBS analyst, Jonathan Groberg, raised his PT on Charles River Labs (NYSE: CRL) to $83 from $76 but maintained his ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found